Literature DB >> 6988303

Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin.

E Hahn, G Wick, D Pencev, R Timpl.   

Abstract

Specific antibodies to collagen type IV, laminin, and fibronectin were used to localise these proteins by indirect immunofluorescence in frozen sections of normal and fibrotic liver. In normal livers distinct staining was found in basement membranes of blood and lymph vessels, of bile ducts and ductules and around nerve axons. Positive reactions for type IV collagen and fibronectin were also observed in the perisinusoidal space, while hepatocytes and most of the interstitial matrix of portal fields remained unstained. Liver specimens obtained from patients with alcoholic liver disease (fatty liver, hepatitis or cirrhosis) and chronic active hepatitis showed a more intense reaction with the antibodies in the perisnusoidal space including now distinct staining for laminin. These patterns were particularly prominent at borders between fibrotic septa and remnants of parenchyma or pseudolobules. Strong reactions were also found for type IV collagen and fibronectin in the periportal interstitium and in large fibrotic areas. The findings support previous electron-microscopical and chemical evidence for increased basement membrane production in human liver fibrosis and demonstrate that this may involve different proteins and occur at different anatomical sites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988303      PMCID: PMC1419572          DOI: 10.1136/gut.21.1.63

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen.

Authors:  A Vaheri; M Kurkinen; V P Lehto; E Linder; R Timpl
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  [Immunohistological demonstration of type I and type III collagen in liver biopsies: early and late changes in alcoholic liver diseases].

Authors:  U Ott; E Hahn; E Moshudis; J C Bode; G A Martini
Journal:  Verh Dtsch Ges Inn Med       Date:  1977 Apr 17-21

3.  Isolation and characterization of a native placental basement-membrane collagen and its component alpha chains.

Authors:  R W Glanville; A Rauter; P P Fietzek
Journal:  Eur J Biochem       Date:  1979-04-02

4.  Identification of a new basement membrane collagen by the aid of a large fragment resistant to bacterial collagenase.

Authors:  R Timpl; J Risteli; H P Bächinger
Journal:  FEBS Lett       Date:  1979-05-15       Impact factor: 4.124

5.  Nature of the collagenous protein in a tumor basement membrane.

Authors:  R Timpl; G R Martin; P Bruckner; G Wick; H Wiedemann
Journal:  Eur J Biochem       Date:  1978-03

6.  Collagen types in normal and cirrhotic liver.

Authors:  M Rojkind; M A Giambrone; L Biempica
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

7.  The diagnostic application of specific antiprocollagen sera. II. Analysis of liver biopsies.

Authors:  G Wick; H Brunner; E Penner; R Timpl
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

8.  Contractile fibroblasts in chronic alcoholic cirrhosis.

Authors:  R Rudolph; W J McClure; M Woodward
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

9.  Synthesis and extracellular deposition of fibronectin in chondrocyte cultures. Response to the removal of extracellular cartilage matrix.

Authors:  W Dessau; J Sasse; R Timpl; F Jilek; K von der Mark
Journal:  J Cell Biol       Date:  1978-11       Impact factor: 10.539

10.  Distribution of a major connective tissue protein, fibronectin, in normal human tissues.

Authors:  S Stenman; A Vaheri
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  98 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 2.  Fibronectin: functional character and role in alcoholic liver disease.

Authors:  Razia S Aziz-Seible; Carol A Casey
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

3.  Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo.

Authors:  J J Maher; R F McGuire
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 4.  Connective tissue components of the normal and fibrotic human liver. II. Clinical aspects.

Authors:  G Pott; J Rauterberg; B Voss; U Gerlach
Journal:  Klin Wochenschr       Date:  1982-01-04

5.  Laminin and vascular proliferation in rheumatoid arthritis.

Authors:  D L Scott; M Salmon; C J Morris; A C Wainwright; K W Walton
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

6.  Distribution of collagen types I and III and basal lamina in human gastric carcinoma: an immunohistochemical and electron microscopic study.

Authors:  M Yamamoto; H Sumiyoshi; K Nakagami; K Taniyama; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

7.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

8.  Fibronectin in the synovium of chronic inflammatory joint disease.

Authors:  V Mayston; P I Mapp; P G Davies; P A Revell
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

9.  Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers.

Authors:  Y Fukuda; M Imoto; Y Koyama; Y Miyazawa; I Nakano; M Hattori; F Urano; S Kodama; K Iwata; T Hayakawa
Journal:  Gastroenterol Jpn       Date:  1991-02

10.  Sequential changes of extracellular matrix and proliferation of Ito cells with enhanced expression of desmin and actin in focal hepatic injury.

Authors:  K Ogawa; J Suzuki; H Mukai; M Mori
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.